Search results
TauRx Submits UK Marketing Authorisation Application for HMTM as a Treatment for Alzheimer's Disease
Financial Post· 2 days agoTauRx Pharmaceuticals Ltd, a global leader in tau-based research in Alzheimer’s disease (AD), has announced the submission of a UK Marketing Authorisation Application (MAA ...